{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:28:48Z","timestamp":1792222128963,"version":"4.4.0"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T00:00:00Z","timestamp":1567987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Investissements d\u2019Avenir program managed by the ANR","award":["ANR-10-LABX-77-01"],"award-info":[{"award-number":["ANR-10-LABX-77-01"]}]},{"name":"Agence Nationale pour la Recherche sur le SIDA et les hepatites virales (ANRS), the Vaccine Research Institute"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1008011","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T17:24:16Z","timestamp":1568049856000},"page":"e1008011","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":34,"title":["Anti-HIV potency of T-cell responses elicited by dendritic cell therapeutic vaccination"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3312-7871","authenticated-orcid":true,"given":"Mathieu","family":"Surenaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7302-8002","authenticated-orcid":true,"given":"Cecilia S.","family":"Lindestam Arlehamn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Banchereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Palucka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8182-3628","authenticated-orcid":true,"given":"Jean-Daniel","family":"Leli\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6925-0225","authenticated-orcid":true,"given":"Christine","family":"Lacabaratz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-6256","authenticated-orcid":true,"given":"Yves","family":"L\u00e9vy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,9,9]]},"reference":[{"key":"ppat.1008011.ref001","unstructured":"UNAIDS Global HIV & AIDS statistics\u20142018 fact sheet. Available from: http:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"issue":"13","key":"ppat.1008011.ref002","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"FJ Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"6","key":"ppat.1008011.ref003","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"ppat.1008011.ref004","first-page":"127","article-title":"Safety and Tolerability: Current Challenges to Antiretroviral Therapy for the Long-Term Management of HIV Infection","volume":"18","author":"J Troya","year":"2016","journal-title":"AIDS Rev"},{"issue":"2","key":"ppat.1008011.ref005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/187152611795589663","article-title":"HIV treatment adherence, drug resistance, virologic failure: evolving concepts","volume":"11","author":"JB Nachega","year":"2011","journal-title":"Infect Disord Drug Targets"},{"issue":"12","key":"ppat.1008011.ref006","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cid\/ciu701","article-title":"Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study","volume":"59","author":"J Schouten","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2","key":"ppat.1008011.ref007","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/QAI.0000000000000825","article-title":"Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study","volume":"71","author":"RA Legarth","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"5341","key":"ppat.1008011.ref008","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"D Finzi","year":"1997","journal-title":"Science"},{"issue":"11","key":"ppat.1008011.ref009","doi-asserted-by":"crossref","first-page":"F79","DOI":"10.1097\/00002030-199907300-00002","article-title":"Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy","volume":"13","author":"F Garc\u00eda","year":"1999","journal-title":"AIDS"},{"issue":"5\u20136","key":"ppat.1008011.ref010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0264-410X(01)00394-2","article-title":"The basis for HIV immunotherapeutic vaccines","volume":"20","author":"BS Peters","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"ppat.1008011.ref011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0952-7915(94)90028-0","article-title":"Structure of peptides associated with MHC class I molecules","volume":"6","author":"VH Engelhard","year":"1994","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"ppat.1008011.ref012","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0952-7915(94)90032-9","article-title":"Origin, structure and motifs of naturally processed MHC class II ligands","volume":"6","author":"O R\u00f6tzschke","year":"1994","journal-title":"Curr Opin Immunol"},{"key":"ppat.1008011.ref013","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1145\/2147805.2147907","article-title":"Using HLA binding prediction algorithms for epitope mapping in HIV vaccine clinical trials","author":"D He","year":"2011","journal-title":"BCB '11 Proceedings of the 2nd ACM Conference on Bioinformatics, Computational Biology and Biomedicine, Chicago, Illinois\u2014August 01\u201303"},{"key":"ppat.1008011.ref014","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3389\/fimmu.2018.02993","article-title":"Using Dendritic Cell-based immunotherapy to treat HIV: How can this strategy be improved?","volume":"9","author":"LT da Silva","year":"2018","journal-title":"Front Immunol"},{"issue":"6673","key":"ppat.1008011.ref015","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"J Banchereau","year":"1998","journal-title":"Nature"},{"issue":"1\u20132","key":"ppat.1008011.ref016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jim.2010.11.002","article-title":"Development of a HIV-1 lipopeptide antigen pulsed therapeutic dendritic cell vaccine","volume":"365","author":"A Cobb","year":"2011","journal-title":"J Immunol Methods"},{"issue":"20","key":"ppat.1008011.ref017","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.77.20.11220-11231.2003","article-title":"Long-term specific immune responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine: characterization of CD8+-T-cell epitopes recognized","volume":"77","author":"H Gah\u00e9ry-S\u00e9gard","year":"2003","journal-title":"J Virol"},{"issue":"3","key":"ppat.1008011.ref018","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/aid.2006.0075","article-title":"HLA-DR-restricted peptides identified in the Nef protein can induce HIV type 1-specific IL-2\/IFN-gamma-secreting CD4+ and CD4+ \/CD8+ T cells in humans after lipopeptide vaccination","volume":"23","author":"H Gahery","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"14","key":"ppat.1008011.ref019","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/QAD.0b013e32833ce566","article-title":"Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trial","volume":"24","author":"D Salmon-C\u00e9ron","year":"2010","journal-title":"AIDS"},{"issue":"9","key":"ppat.1008011.ref020","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1002\/eji.201344433","article-title":"Dendritic cell-based therapeutic vaccine elicits polyfunctional HIV-specific T-cell immunity associated with control of viral load","volume":"44","author":"Y L\u00e9vy","year":"2014","journal-title":"Eur J Immunol"},{"issue":"3","key":"ppat.1008011.ref021","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/imm.12889","article-title":"Improved methods for predicting peptide binding affinity to MHC class II molecules","volume":"154","author":"KK Jensen","year":"2018","journal-title":"Immunology"},{"issue":"9","key":"ppat.1008011.ref022","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","article-title":"NetMHCpan-4.0: Improved Peptide-MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data","volume":"199","author":"V Jurtz","year":"2017","journal-title":"J Immunol"},{"issue":"7","key":"ppat.1008011.ref023","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e328337b144","article-title":"Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection","volume":"24","author":"E Nemes","year":"2010","journal-title":"AIDS"},{"issue":"123","key":"ppat.1008011.ref024","doi-asserted-by":"crossref","first-page":"123ra25","DOI":"10.1126\/scitranslmed.3003165","article-title":"HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome","volume":"4","author":"DZ Soghoian","year":"2012","journal-title":"Sci Transl Med"},{"issue":"3","key":"ppat.1008011.ref025","first-page":"279","article-title":"Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients","volume":"19","author":"Y L\u00e9vy","year":"2005","journal-title":"AIDS"},{"issue":"4","key":"ppat.1008011.ref026","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.vaccine.2013.11.052","article-title":"Memory CD8(+) T cells elicited by HIV-1 lipopeptide vaccines display similar phenotypic profiles but differences in term of magnitude and multifunctionality compared with FLU- or EBV-specific memory T cells in humans","volume":"32","author":"S Figueiredo","year":"2014","journal-title":"Vaccine"},{"issue":"9","key":"ppat.1008011.ref027","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1002\/eji.200737365","article-title":"Extensive HLA class I allele promiscuity among viral CTL epitopes","volume":"37","author":"N Frahm","year":"2007","journal-title":"Eur J Immunol"},{"issue":"10","key":"ppat.1008011.ref028","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1371\/journal.pone.0000984","article-title":"Design and pre-clinical evaluation of a universal HIV-1 vaccine","volume":"2","author":"S L\u00e9tourneau","year":"2007","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1008011.ref029","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12977-018-0429-y","article-title":"CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication","volume":"15","author":"H Murakoshi","year":"2018","journal-title":"Retrovirology"},{"issue":"7","key":"ppat.1008011.ref030","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1089\/aid.2005.21.620","article-title":"Cross-clade conservation of HIV type 1 Nef immunodominant regions recognized by CD8+ T cells of HIV type 1 CRF02_AG-infected Ivorian (West Africa)","volume":"21","author":"A Inwoley","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"9","key":"ppat.1008011.ref031","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1172\/JCI4314","article-title":"Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi","volume":"102","author":"SL Rowland-Jones","year":"1998","journal-title":"J Clin Invest"},{"issue":"5","key":"ppat.1008011.ref032","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/00002030-200403260-00005","article-title":"Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection","volume":"18","author":"SE Gloster","year":"2004","journal-title":"AIDS"},{"issue":"11","key":"ppat.1008011.ref033","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1089\/088922299310485","article-title":"Lymphoproliferative response to HIV type 1 p24 in long-term survivors of HIV type 1 infection is predictive of persistent AIDS-free infection","volume":"15","author":"O Pontesilli","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5342","key":"ppat.1008011.ref034","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1126\/science.278.5342.1447","article-title":"Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia","volume":"278","author":"ES Rosenberg","year":"1997","journal-title":"Science"},{"key":"ppat.1008011.ref035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/1742-4690-5-112","article-title":"Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection","volume":"5","author":"WB Dyer","year":"2008","journal-title":"Retrovirology"},{"issue":"12","key":"ppat.1008011.ref036","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1084\/jem.20031598","article-title":"HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity","volume":"198","author":"SA Younes","year":"2003","journal-title":"J Exp Med"},{"issue":"6","key":"ppat.1008011.ref037","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1084\/jem.20041270","article-title":"Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells","volume":"200","author":"M Lichterfeld","year":"2004","journal-title":"J Exp Med"},{"issue":"11","key":"ppat.1008011.ref038","doi-asserted-by":"crossref","first-page":"6376","DOI":"10.4049\/jimmunol.169.11.6376","article-title":"Presence of HIV-1 Gag-specific IFN-gamma+IL-2+ and CD28+IL-2+ CD4 T cell responses is associated with nonprogression in HIV-1 infection","volume":"169","author":"MJ Boaz","year":"2002","journal-title":"J Immunol"},{"issue":"3","key":"ppat.1008011.ref039","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1182\/blood-2003-04-1203","article-title":"Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy","volume":"103","author":"A Harari","year":"2004","journal-title":"Blood"},{"issue":"22","key":"ppat.1008011.ref040","doi-asserted-by":"crossref","first-page":"14169","DOI":"10.1128\/JVI.79.22.14169-14178.2005","article-title":"Phenotypic, functional, and kinetic parameters associated with apparent T-cell control of human immunodeficiency virus replication in individuals with and without antiretroviral treatment","volume":"79","author":"B Emu","year":"2005","journal-title":"J Virol"},{"issue":"24","key":"ppat.1008011.ref041","doi-asserted-by":"crossref","first-page":"13904","DOI":"10.1128\/JVI.01401-07","article-title":"Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study","volume":"81","author":"SJ Potter","year":"2007","journal-title":"J Virol"},{"issue":"12","key":"ppat.1008011.ref042","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/nm1147","article-title":"Therapeutic dendritic-cell vaccine for chronic HIV-1 infection","volume":"10","author":"W Lu","year":"2004","journal-title":"Nat Med"},{"key":"ppat.1008011.ref043","doi-asserted-by":"crossref","first-page":"28129","DOI":"10.1038\/srep28129","article-title":"HIV-specific Th2 and Th17 responses predict HIV vaccine protection efficacy","volume":"6","author":"D Sauce","year":"2016","journal-title":"Sci Rep"},{"issue":"6","key":"ppat.1008011.ref044","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/s41591-018-0025-7","article-title":"HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition","volume":"24","author":"M Vaccari","year":"2018","journal-title":"Nat Med"},{"issue":"9","key":"ppat.1008011.ref045","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/QAD.0b013e32835f5b60","article-title":"Cytokine and gene transcription profiles of immune responses elicited by HIV lipopeptide vaccine in HIV-negative volunteers","volume":"27","author":"L Richert","year":"2013","journal-title":"AIDS"},{"key":"ppat.1008011.ref046","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ebiom.2017.09.028","article-title":"Cell-Mediated Immune Predictors of Vaccine Effect on Viral Load and CD4 Count in a Phase 2 Therapeutic HIV-1 Vaccine Clinical Trial","volume":"24","author":"Y Huang","year":"2017","journal-title":"EBioMedicine"},{"issue":"2","key":"ppat.1008011.ref047","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.178.2.743","article-title":"Interleukin 13 inhibits human immunodeficiency virus type 1 production in primary blood-derived human macrophages in vitro","volume":"178","author":"LJ Montaner","year":"1993","journal-title":"J Exp Med"},{"issue":"12","key":"ppat.1008011.ref048","doi-asserted-by":"crossref","first-page":"7534","DOI":"10.4049\/jimmunol.162.12.7534","article-title":"IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression","volume":"162","author":"RT Bailer","year":"1999","journal-title":"J Immunol"},{"issue":"8","key":"ppat.1008011.ref049","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.4049\/jimmunol.175.8.5532","article-title":"IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes","volume":"175","author":"E Papasavvas","year":"2005","journal-title":"J Immunol"},{"issue":"6","key":"ppat.1008011.ref050","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/infdis\/jiu534","article-title":"Alternative effector-function profiling identifies broad HIV-specific T-cell responses in highly HIV-exposed individuals who remain uninfected","volume":"211","author":"M Ruiz-Riol","year":"2015","journal-title":"J Infect Dis"},{"issue":"9","key":"ppat.1008011.ref051","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1128\/JVI.75.9.4195-4207.2001","article-title":"Identification and antigenicity of broadly cross-reactive and conserved human immunodeficiency virus type 1-derived helper T-lymphocyte epitopes","volume":"75","author":"CC Wilson","year":"2001","journal-title":"J Virol"},{"issue":"9","key":"ppat.1008011.ref052","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1128\/JVI.78.9.4463-4477.2004","article-title":"Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides","volume":"78","author":"DE Kaufmann","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"ppat.1008011.ref053","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.qai.0000195608.32885.38","article-title":"HIV-1-specific CD4+ T-cell responses are not associated with significant viral epitope variation in persons with persistent plasma viremia","volume":"41","author":"JR Koeppe","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ppat.1008011.ref054","doi-asserted-by":"crossref","first-page":"e8574","DOI":"10.1371\/journal.pone.0008574","article-title":"Dendritic cell mediated delivery of plasmid DNA encoding LAMP\/HIV-1 Gag fusion immunogen enhances T cell epitope responses in HLA DR4 transgenic mice","volume":"5","author":"GG Simon","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"ppat.1008011.ref055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.4049\/jimmunol.162.1.152","article-title":"Identification of a conserved universal Th epitope in HIV-1 reverse transcriptase that is processed and presented to HIV-specific CD4+ T cells by at least four unrelated HLA-DR molecules","volume":"162","author":"SH van der Burg","year":"1999","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1008011.ref056","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.05577-11","article-title":"HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome","volume":"86","author":"S Ranasinghe","year":"2012","journal-title":"J Virol"},{"issue":"7","key":"ppat.1008011.ref057","doi-asserted-by":"crossref","first-page":"e39874","DOI":"10.1371\/journal.pone.0039874","article-title":"Characterization of HIV-specific CD4+ T cell responses against peptides selected with broad population and pathogen coverage","volume":"7","author":"M Buggert","year":"2012","journal-title":"PLoS One"},{"issue":"13","key":"ppat.1008011.ref058","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1128\/JVI.00728-14","article-title":"Induction of Gag-specific CD4 T cell responses during acute HIV infection is associated with improved viral control","volume":"88","author":"M Schieffer","year":"2014","journal-title":"J Virol"},{"issue":"31","key":"ppat.1008011.ref059","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1016\/j.vaccine.2007.05.038","article-title":"Presence of HIV-1 Nef specific CD4 T cell response is associated with non-progression in HIV-1 infection","volume":"25","author":"V Pancr\u00e9","year":"2007","journal-title":"Vaccine"},{"issue":"7","key":"ppat.1008011.ref060","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humimm.2008.05.001","article-title":"Balancing selection and heterogeneity across the classical human leukocyte antigen loci: a meta-analytic review of 497 population studies","volume":"69","author":"OD Solberg","year":"2008","journal-title":"Hum Immunol"},{"issue":"11","key":"ppat.1008011.ref061","doi-asserted-by":"crossref","first-page":"5757","DOI":"10.4049\/jimmunol.1300145","article-title":"Hierarchy of CD4 T cell epitopes of the ANRS Lipo5 synthetic vaccine relies on the frequencies of pre-existing peptide-specific T cells in healthy donors","volume":"190","author":"FA Castelli","year":"2013","journal-title":"J Immunol"},{"issue":"7","key":"ppat.1008011.ref062","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nm.3229","article-title":"Association of HLA-DRB1-restricted CD4\u207a T cell responses with HIV immune control","volume":"19","author":"S Ranasinghe","year":"2013","journal-title":"Nat Med"},{"issue":"166","key":"ppat.1008011.ref063","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"F Garc\u00eda","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"ppat.1008011.ref064","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/QAI.0000000000000926","article-title":"Dendritic Cell Immunotherapy for HIV-1 Infection Using Autologous HIV-1 RNA: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","volume":"72","author":"JM Jacobson","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ppat.1008011.ref065","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ebiom.2016.01.029","article-title":"Functional Specialty of CD40 and Dendritic Cell Surface Lectins for Exogenous Antigen Presentation to CD8(+) and CD4(+) T Cells","volume":"5","author":"W Yin","year":"2016","journal-title":"EBioMedicine"},{"issue":"13","key":"ppat.1008011.ref066","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/QAD.0b013e3283624305","article-title":"Targeting concatenated HIV antigens to human CD40 expands a broad repertoire of multifunctional CD4+ and CD8+ T cells","volume":"27","author":"AL Flamar","year":"2013","journal-title":"AIDS"},{"issue":"11","key":"ppat.1008011.ref067","doi-asserted-by":"crossref","first-page":"e0207794","DOI":"10.1371\/journal.pone.0207794","article-title":"HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates","volume":"13","author":"AL Flamar","year":"2018","journal-title":"PLoS One"},{"issue":"10","key":"ppat.1008011.ref068","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1172\/JCI99005","article-title":"TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs","volume":"128","author":"L Cheng","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"ppat.1008011.ref069","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/COH.0000000000000324","article-title":"Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change","volume":"11","author":"G Pantaleo","year":"2016","journal-title":"Curr Opin HIV AIDS"}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1008011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T01:45:36Z","timestamp":1695174336000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1008011"}},"subtitle":[],"editor":[{"given":"Guido","family":"Silvestri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,9,9]]},"references-count":69,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1008011","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,9]]}}}